跳至主要内容
临床试验/CTIS2023-504915-34-00
CTIS2023-504915-34-00进行中(未招募)1 期

Dose-finding for dobutamine during transitional circulation in the very preterm infant - NeoCirc-002 TRIA

Hospital Universitario La Paz0 个研究点目标入组 25 人开始时间: 2023年4月18日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
0 至 17(—)
性别
All

入选标准

  • Born up to 32(+6) weeks gestation, Presence of haemodynamic insufficiency, defined as SVC flow <51 ml/kg/min., Provision of signed and dated informed consent form by father/mother or legally designated representative, which can be given antenatally as described in section 5.4.

排除标准

  • Neonates considered non-viable, with a clinical decision not to provide life support, Infants with severe congenital hydrops fetalis needing chest or peritoneal drainage before recruitment, Infants already on dobutamine treatment, Infants with congenital malformations likely to affect cardiovascular adaptation (including: congenital diaphragmatic hernia, gastroschisis or congenital heart defects)., Infants carrying chromosomal anomalies, Lack of parental signed informed consent

研究者

相似试验